hiPS Neuronal Cells for Botulinum Toxin Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Clostridium botulinum neurotoxin (BoNT) are either non-specific, require large animal testing, or lack sensitivity, making them inadequate for accurate potency determination and neutralizing antibody screening, particularly in pharmaceutical and cosmetic applications.
Innovation Solution
The use of human induced pluripotent stem (hiPS) derived neuronal cells for BoNT detection and analysis, which are highly sensitive and reproducible, allowing for quantitative detection of all BoNT serotypes and neutralizing antibodies, reducing the need for animal testing and enabling more efficient screening and quality control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional detection methods (ELISA, mouse bioassay) are used, then detection capability is achieved, but sensitivity and species-specificity are insufficient
Solution Approach 1:
The patent uses human iPSC-derived neuronal cells as an intermediary system that bridges the gap between traditional detection methods and the need for high sensitivity and species-specificity. These cells express human SNARE proteins that serve as specific targets for BoNT, enabling highly sensitive and species-specific detection without requiring animal testing
Solution Approach 2:
The invention changes the detection parameter from using animal models or non-specific immunological assays to using human neuronal cells with specific SNARE protein expression. This parameter change enables both high sensitivity (detecting low levels of toxin) and species-specificity (distinguishing BoNT from other neurotoxins) simultaneously
2Measurement precision
If mouse bioassay is used for potency determination, then quantitative detection is achieved, but animal testing requirements increase
Solution Approach 1:
The patent replaces the mechanical/biological system of whole animal testing with an in vitro cell-based assay system. Human iPSC-derived neuronal cells are cultured in controlled conditions and exposed to BoNT, allowing quantitative potency determination through measurement of SNARE protein cleavage or neuronal function assays, eliminating the need for live animal testing
Solution Approach 2:
The invention creates a simplified copy of the biological system - using human neuronal cells in culture that replicate the key functional elements (SNARE proteins, neuronal membrane) necessary for BoNT action. This cell-based model serves as a substitute for the complex whole animal system while maintaining the ability to perform quantitative potency assessment
3Adaptability or versatility
If non-specific detection methods are used, then broad screening capability is achieved, but detection accuracy decreases
Solution Approach 1:
The patent applies local quality by designing the assay to specifically detect BoNT through its unique interaction with human SNARE proteins in neuronal cells. The detection system is locally optimized for BoNT specificity through the selective expression of human SNARE targets that are cleaved by BoNT but not by other neurotoxins, enabling both broad screening and high accuracy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a species-specific, sensitive, and quantitative method for BoNT detection and analysis, improving the accuracy of potency determination and neutralizing antibody screening, and reducing the reliance on animal testing, thus enhancing safety and quality control in pharmaceutical and cosmetic applications.
Implementation Method 1
The HC C domain is responsible for recognition and binding to specific neuronal cell surface receptors leading to endocytosis
Implementation Method 2
The HC C domain is responsible for recognition and binding to specific neuronal cell surface receptors leading to endocytosis
Implementation Method 3
the HC N domain is responsible for channel formation in the endocytic vesicle membrane and translocation and internalization of the LC across the endosomal membrane
Implementation Method 4
The LC then specifically targets and cleaves an intracellular SNARE protein at the pre-synaptic vesicles, which leads to inhibition of neurotransmitter release
Data Source
Figure 1A~2
Figure 3~4
Figure 5
AI summary
The present invention relates to compositions and methods for testing agents (e.g., Clostridium botulinum neurotoxin (BoNT) detection and analysis). In particular, the present invention relates to the use of Human induced pluripotent stem (hiPS) derived cells for agent detection and analysis.